Contact PI/Project LeaderCHRISTENSEN, BRUCE MARTIN
Awardee OrganizationUNIVERSITY OF WISCONSIN-MADISON
Description
Abstract Text
Immune mechanisms operating in mosquitoes are capable of limiting or
preventing the development of filarial worms within these vectors.
Although melanotic encapsulation reactions are responsible for resistance
in certain species of mosquitoes, parasites are often capable of developing
in other closely related species or even other strains, of the same
species. Why certain mosquito species respond effectively while others do
not, or why a species can immunologically destroy one parasite species but
not another, are questions of fundamental relevance to our understanding of
vector-parasite compatibility. The objective of the proposed research is
to elucidate immune recognition and effector mechanisms and their
regulation in mosquitoes exposed to filarial worms. Various biochemical
and molecular techniques will be used with the mosquitoes Aedes aegypti,
Aedes trivittatus and the filarial worms Brugia malayi, B. pahangi and
Dirofilaria immitis (1) quantitatively assess the role specific enzymes and
substrates might play in the production of protein-polyphenol complexes
required for the immune destruction of microfilariae in mosquitoes, (2)
identify and characterize hemolymph proteins that are uniquely or
preferentially expressed in mosquitoes during melanotic encapsulation
reactions, (3) characterize functional differences in mosquito hemocytes
using lectins and anti-hemocyte monoclonal antibodies, and (4) begin
characterizing immune mechanisms operating in the Armigeres
subalbatus-Brugia spp. vector-parasite system that allows the development
of B. pahangi but results in the immune destruction of B. malayi. The
proposed studies will provide an increased clarification of mechanisms of
immune responses in mosquitoes and a greater insight into vector-parasite
associations, thereby increasing our understanding of the epidemiology of
mosquito-borne filariasis.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
161202122
UEI
LCLSJAGTNZQ7
Project Start Date
01-April-1983
Project End Date
28-February-2001
Budget Start Date
01-May-1999
Budget End Date
28-February-2001
Project Funding Information for 1999
Total Funding
$248,704
Direct Costs
$173,919
Indirect Costs
$74,785
Year
Funding IC
FY Total Cost by IC
1999
National Institute of Allergy and Infectious Diseases
$248,704
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R37AI019769-17
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R37AI019769-17
Patents
No Patents information available for 5R37AI019769-17
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R37AI019769-17
Clinical Studies
No Clinical Studies information available for 5R37AI019769-17
News and More
Related News Releases
No news release information available for 5R37AI019769-17
History
No Historical information available for 5R37AI019769-17
Similar Projects
No Similar Projects information available for 5R37AI019769-17